Xiaoyan Liu

2.6k total citations
148 papers, 1.7k citations indexed

About

Xiaoyan Liu is a scholar working on Psychiatry and Mental health, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Xiaoyan Liu has authored 148 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Psychiatry and Mental health, 53 papers in Oncology and 31 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Xiaoyan Liu's work include Epilepsy research and treatment (49 papers), Cancer Immunotherapy and Biomarkers (22 papers) and Pharmacological Effects and Toxicity Studies (20 papers). Xiaoyan Liu is often cited by papers focused on Epilepsy research and treatment (49 papers), Cancer Immunotherapy and Biomarkers (22 papers) and Pharmacological Effects and Toxicity Studies (20 papers). Xiaoyan Liu collaborates with scholars based in China, United States and Switzerland. Xiaoyan Liu's co-authors include Yuehua Zhang, Zhixian Yang, Xiru Wu, Jiong Qin, Yuwu Jiang, Minjiang Chen, Demetrius M. Kokkinakis, Mengzhao Wang, Yan Xu and Ye Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Physics Letters and PLoS ONE.

In The Last Decade

Xiaoyan Liu

137 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyan Liu China 24 483 417 391 225 191 148 1.7k
Christopher D. Stephen United States 19 425 0.9× 1.2k 2.8× 790 2.0× 272 1.2× 89 0.5× 75 3.6k
Susan L. Connors United States 26 410 0.8× 1.1k 2.5× 400 1.0× 131 0.6× 220 1.2× 37 2.7k
Lijun Jiang China 26 302 0.6× 482 1.2× 400 1.0× 42 0.2× 92 0.5× 89 1.9k
Susanne Englisch Germany 21 706 1.5× 915 2.2× 615 1.6× 126 0.6× 151 0.8× 46 2.9k
Rui Gao China 26 184 0.4× 697 1.7× 232 0.6× 129 0.6× 78 0.4× 120 1.9k
Yijun Liu China 27 519 1.1× 254 0.6× 173 0.4× 76 0.3× 102 0.5× 97 2.4k
Yu‐Chiau Shyu Taiwan 22 264 0.5× 604 1.4× 173 0.4× 112 0.5× 60 0.3× 76 1.6k
David S. Lee United States 21 358 0.7× 197 0.5× 278 0.7× 55 0.2× 92 0.5× 65 2.1k
Pin‐Yuan Chen Taiwan 30 169 0.3× 675 1.6× 202 0.5× 119 0.5× 69 0.4× 105 3.4k
Timothy J. Kendall United Kingdom 34 578 1.2× 823 2.0× 576 1.5× 105 0.5× 141 0.7× 107 4.9k

Countries citing papers authored by Xiaoyan Liu

Since Specialization
Citations

This map shows the geographic impact of Xiaoyan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Liu more than expected).

Fields of papers citing papers by Xiaoyan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Liu. The network helps show where Xiaoyan Liu may publish in the future.

Co-authorship network of co-authors of Xiaoyan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Liu. A scholar is included among the top collaborators of Xiaoyan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Liu. Xiaoyan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chan, Phyllis, Nathalie Gosselin, Mathilde Marchand, et al.. (2025). Population Pharmacokinetics and Exposure‐Response of Subcutaneous Atezolizumab in Patients With Non‐Small Cell Lung Cancer. CPT Pharmacometrics & Systems Pharmacology. 14(4). 726–737. 2 indexed citations
3.
Wei, Chunli, Xiaoyan Liu, Lisha Yang, et al.. (2025). Exploring breast cancer associated-gene panel for next-generation sequencing and identifying new, pathogenic variants in breast cancer from western China. Journal of Cancer. 16(4). 1281–1295. 1 indexed citations
4.
Cai, Yong, Weiwei Wang, Qinlian Jiao, et al.. (2024). Nanotechnology for the Diagnosis and Treatment of Liver Cancer. International Journal of Nanomedicine. Volume 19. 13805–13821. 3 indexed citations
5.
Gao, Hua, et al.. (2024). Rutaecarpine Aggravates Acetaminophen-Induced Acute Liver Injury by Inducing CYP1A2. Toxics. 12(7). 515–515. 1 indexed citations
6.
Deng, Meng, et al.. (2024). Economic evaluation of cemiplimab plus chemotherapy regimen for advanced non-small-cell lung cancer. BMC Cancer. 24(1). 1 indexed citations
8.
Liu, Xiaoyan, Huijun Zhou, Minghui Li, et al.. (2023). An occupational health survey on health utility and occupational diseases in Chinese university staff to inform cost-utility analysis. Frontiers in Public Health. 10. 1022344–1022344. 1 indexed citations
9.
Zhu, Ying, Qingzhu Liu, Shuang Zhang, et al.. (2023). Clinical characteristics and surgical outcomes in children with mild malformation of cortical development and oligodendroglial hyperplasia in epilepsy. Epilepsia Open. 8(3). 898–911. 6 indexed citations
10.
Chai, Qingqing, et al.. (2023). Cost-effectiveness of sacituzumab govitecan versus chemotherapy in advanced or metastatic triple-negative breast cancer. The Breast. 68. 173–180. 12 indexed citations
12.
Cai, Lixin, Kai Zhang, Wenjing Zhou, et al.. (2023). Consensus on pediatric epilepsy surgery for young children: an investigation by the China Association Against Epilepsy task force on epilepsy surgery. SHILAP Revista de lepidopterología. 5(1). 20–20. 3 indexed citations
13.
Yang, Tianan, et al.. (2022). What Drives the Influence of Health Science Communication Accounts on TikTok? A Fuzzy-Set Qualitative Comparative Analysis. International Journal of Environmental Research and Public Health. 19(21). 13815–13815. 1 indexed citations
14.
Liu, Xiaoyan, et al.. (2020). The marketing force of sound: the impact of destination song on tourists' attitude-taking "Chengdu" for example.. Luyou xuekan. 35(5). 124–138. 2 indexed citations
15.
Wang, Haixiang, Aileen McGonigal, Kai Zhang, et al.. (2020). Semiologic subgroups of insulo‐opercular seizures based on connectional architecture atlas. Epilepsia. 61(5). 984–994. 27 indexed citations
16.
Wang, Haixiang, Olivier David, Wenjing Zhou, et al.. (2018). Distinctive epileptogenic networks for parietal operculum seizures. Epilepsy & Behavior. 91. 59–67. 5 indexed citations
17.
Liu, Xiaoyan, et al.. (2018). Do rewards impact electronic WOM? A study on the effects of monetary incentives on restaurant customers' eWOM behavior.. Luyou xuekan. 33(10). 75–86. 2 indexed citations
18.
Liu, Xiaoyan. (2014). Tissues Distribution of Icariin and Its Metabolites in Kidney of Osteoporosis Model Rats. Zhongguo shiyan fangjixue zazhi. 2 indexed citations
19.
Kang, Huicong, Xiaoyan Liu, Zhiguang Liu, et al.. (2012). A follow-up study on newer anti-epileptic drugs as add-on and monotherapy for partial epilepsy in China.. PubMed. 125(4). 646–51. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026